Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.15

-0.01 (-0.86%)

As of Feb 8, 2:21 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +3,040.0% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $1.15

Current
$1.15

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

1,940.9%

Low target

Base Case

$36.11

+3,040.0%

Avg target

Bull Case

$39.96

+3,374.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$30.10

-96.2% from high

52-Week Low

$15.80

+-92.7% from low

Target vs 52W High

$36.11

+20.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%